EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtVergleichsstudie

Total disc replacement versus lumbar interbody fusion for degenerative disc disease: a meta-analysis of randomized controlled trials

Shaan Patel, Angelette Mendonca, Shiva A Nischal, Kush M Kale, Kevin Hines, Joshua Heller, Jack Jallo, James S Harrop, Srinivas K Prasad

Neurosurgical Focus · 01.07.2026 · 61 (1) · E11

DOI: 10.3171/2026.3.focus2630 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Neurosurgical Focus, erschienen am 01.07.2026. Verfasst von Shaan Patel und 8 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Total Disc Replacement, Spinal Fusion, Intervertebral Disc Degeneration, Lumbar Vertebrae. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 112 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Lumbar total disc replacement (TDR) was developed as a motion-preserving alternative to interbody fusion (IBF) for degenerative disc disease (DDD), yet comparative benefits remain debated. This systematic review and meta-analysis of randomized controlled trials (RCTs) aimed to compare clinical, perioperative, and durability-related outcomes between lumbar TDR and IBF. METHODS The PubMed, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) databases were searched from inception to December 30, 2025, for RCTs comparing lumbar TDR with IBF (including anterior and posterior fusion approaches) in adults with DDD. Primary outcomes were overall complications, reoperations, and trial-defined overall success. Secondary outcomes included pain, disability, quality of life, perioperative metrics, pseudarthrosis, adjacent segment disease (ASD), device-related complications, and patient satisfaction outcomes. Random-effects meta-analyses were conducted throughout. Risk of bias was assessed using Cochrane’s risk-of-bias tool 2, and certainty of evidence evaluated with the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. RESULTS Thirteen RCTs comprising 2349 patients (1549 with TDR, 800 with IBF) with a mean follow-up 44 months were included. TDR was associated with a significantly lower risk of overall complications (31.4% vs 35.4%, risk ratio [RR] 0.75, 95% confidence interval [CI] 0.61–0.93; p < 0.01) and reoperation (6.1% vs 11.9%, RR 0.48, 95% CI 0.34–0.69; p < 0.0001). Risk of ASD (3.7% vs 8.3%, RR 0.41, 95% CI 0.23–0.75; p < 0.01) and pseudarthrosis (0.1% vs 6.5%, RR 0.07, 95% CI 0.02–0.25; p < 0.0001) were lower following TDR. Pain and disability outcomes favored TDR at early and intermediate follow-ups but converged with fusion outcomes by 5 years. Operative time and blood loss did not differ significantly between approaches, while hospital length of stay showed a borderline reduction favoring TDR (mean difference −0.53 days, 95% CI −1.06 to 0.00 days; p = 0.05). Long-term patient satisfaction and return-to-work outcomes were comparable, but narcotic use at the last follow-up was significantly lower following TDR (38.6% vs 55.7%, RR 0.68, 95% CI 0.58–0.81; p < 0.0001). Overall risk of bias across trials was moderate, and certainty of evidence for primary outcomes was graded as moderate, with downgrading primarily driven by risk of bias and heterogeneity. CONCLUSIONS In carefully selected patients undergoing surgery for lumbar DDD, TDR lowers overall complications and reoperation risk compared with IBF, driven by reductions in pseudarthrosis and ASD, while achieving comparable long-term patient-reported outcomes. The principal advantage of arthroplasty appears to be mechanical durability and reduced revision burden rather than sustained superiority in conventional functional scores. Systematic review registration no.: CRD420251271692 ( https://www.crd.york.ac.uk/prospero/ )

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Total Disc ReplacementSpinal FusionIntervertebral Disc DegenerationLumbar VertebraeHumansRandomized Controlled Trials as TopicTreatment OutcomePostoperative ComplicationsPatient Satisfaction

Stichwörter der Autor:innen

arthroplastydisc replacementinterbody fusionlumbar surgery

Autor:innen und Institutionen

  • 1Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.
  • 2School of Clinical Medicine, University of Cambridge; and.
  • 3Department of Physiology, Anatomy & Genetics, Medical Sciences Division, University of Oxford, United Kingdom.

Zitieren

APA

Patel, S., Mendonca, A., Nischal, S. A., Kale, K. M., Hines, K., Heller, J., Jallo, J., Harrop, J. S., & Prasad, S. K. (2026). Total disc replacement versus lumbar interbody fusion for degenerative disc disease: a meta-analysis of randomized controlled trials. Neurosurgical Focus, 61(1), E11. https://doi.org/10.3171/2026.3.focus2630

Vancouver

Patel S, Mendonca A, Nischal SA, Kale KM, Hines K, Heller J, et al. Total disc replacement versus lumbar interbody fusion for degenerative disc disease: a meta-analysis of randomized controlled trials. Neurosurgical Focus. 2026;61(1):E11. doi:10.3171/2026.3.focus2630

BibTeX
@article{Patel2026,
  author = {Patel, Shaan and Mendonca, Angelette and Nischal, Shiva A and Kale, Kush M and Hines, Kevin and Heller, Joshua and Jallo, Jack and Harrop, James S and Prasad, Srinivas K},
  title = {Total disc replacement versus lumbar interbody fusion for degenerative disc disease: a meta-analysis of randomized controlled trials},
  journal = {Neurosurgical Focus},
  year = {2026},
  volume = {61},
  number = {1},
  pages = {E11},
  doi = {10.3171/2026.3.focus2630}
}
Kostenlos starten →